DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -94.3% | 1,104 | -94.2% | 0.00% | – |
| Q3 2016 | $88,000 | +2100.0% | 19,032 | +1422.6% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 1,250 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -96.3% | 1,250 | -93.0% | 0.00% | – |
| Q4 2015 | $81,000 | -82.3% | 17,895 | -81.6% | 0.00% | – |
| Q3 2015 | $457,000 | -67.5% | 97,189 | -50.5% | 0.00% | -100.0% |
| Q2 2015 | $1,406,000 | +77.1% | 196,476 | +109.3% | 0.00% | – |
| Q1 2015 | $794,000 | +20.3% | 93,865 | +32.2% | 0.00% | – |
| Q4 2014 | $660,000 | +27.9% | 71,009 | +14.4% | 0.00% | – |
| Q3 2014 | $516,000 | -1.3% | 62,058 | +37.0% | 0.00% | – |
| Q2 2014 | $523,000 | -0.6% | 45,283 | +8.8% | 0.00% | – |
| Q1 2014 | $526,000 | +1596.8% | 41,609 | +1340.8% | 0.00% | – |
| Q4 2013 | $31,000 | -84.7% | 2,888 | -82.4% | 0.00% | – |
| Q3 2013 | $202,000 | – | 16,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |